Evidence map›Paper›PMID 29271864›Full record

ArticlePsychosomatic medicine2018

Accelerated DNA Methylation Age: Associations With Posttraumatic Stress Disorder and Mortality.

Erika J Wolf, Mark W Logue, Tawni B Stoop, Steven A Schichman, Annjanette Stone, Naomi Sadeh, Jasmeet P Hayes, Mark W Miller

Abstract read
In one paragraph

Article in Psychosomatic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 7 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 7 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. A Systematic Review and Meta-analysis of Environmental, Lifestyle, and Health Factors Associated With DNA Methylation Age.The journals of gerontology. Series A, Biological sciences and medical sciences · 2020
    Pooled it
  6. Pooled it
  7. Pooled it
  8. DNA methylation GrimAge acceleration in US military veterans with PTSD.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Erika J WolfFrom the National Center for PTSD (Wolf, Logue, Sadeh, Hayes, Miller), Behavioral Science Division, VA Boston Healthcare System; Department of Psychiatry (Wolf, Sadeh, Hayes, Miller), Boston University School of Medicine; Biomedical Genetics (Logue), Boston University School of Medicine; Department of Biostatistics (Logue), Boston University School of Public Health; Research Service (Stoop), VA Boston Healthcare System; and Pharmacogenomics Analysis Laboratory (Schichman, Stone), Research Service, Central Arkansas Veterans Healthcare System, Boston, Massachusetts.
Mark W Logue
Tawni B Stoop
Steven A Schichman
Annjanette Stone
Naomi Sadeh
Jasmeet P Hayes
Mark W Miller
Boston University · US

Funding

The Genetics of Negative Conflict BehaviorR01MH079806 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MILLER, MARK W · 2007 to 2011
$1.5M
Traumatic Stress and Accelerated Aging in DNA MethylationR03AG051877 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLF, ERIKA J · 2016 to 2017
$179k
Analysis of RORA and other candidate genes in PTSDI01BX002150 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MILLER, MARK W · 2013 to 2015
–
The Structure of PTSD ComorbidityI01CX000431 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MILLER, MARK W · 2011 to 2014
–
PTSD-Related Accelerated Aging in DNA Methylation and Risk for Metabolic SyndromeI01CX001276 · VA · VA BOSTON HEALTH CARE SYSTEM · PI WOLF, ERIKA J · 2016 to 2021
–
BLRD VA I01 BX002150CSRD VA I01 CX000431CSRD VA I01 CX001276NIA NIH HHS R03 AG051877NIMH NIH HHS R01 MH079806
6 · The paper itself

Abstract

objectiveRecently developed indices of cellular age based on DNA methylation (DNAm) data, referred to as DNAm age, are being used to study factors that influence the rate of aging and the health correlates of these metrics of the epigenetic clock. This study evaluated associations between trauma exposure, posttraumatic stress disorder (PTSD) symptoms, and accelerated versus decelerated DNAm age among military veterans. We also examined whether accelerated DNAm age predicted mortality over the course of a 6.5-year medical record review period.

methodsThree hundred thirty-nine genotype-confirmed white, non-Hispanic, middle-aged, trauma-exposed veterans underwent psychiatric assessment and genome-wide DNAm analysis. DNAm age was calculated using a previously validated algorithm. Medical records were available for a subset of 241 veterans and were reviewed approximately 6.5 years after DNA collection and PTSD assessment.

resultsPTSD hyperarousal symptoms were associated with accelerated DNAm age (β = 0.20, p = .009) but trauma exposure and total PTSD severity were not. Accelerated DNAm age was also associated with 13% increased risk for all-cause mortality (hazard ratio = 1.13, 95% confidence interval = 1.01-1.26) during the medical record review period.

conclusionsFindings of this study replicate the association between PTSD and accelerated DNAm age and suggest that this effect may be specific to the hyperarousal symptom cluster. Results point to the potential utility of DNAm age algorithms for identifying individuals who are aging at an accelerated rate and for determining the factors that influence this process.

Indexed as

MortalityVeteransAdultCellular SenescenceDNA MethylationFemaleHumansMaleMiddle AgedStress Disorders, Post-Traumatic

Identifiers

PMID29271864
PMCPMC5775924
OpenAlexW2737848064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.